IRME · IR-Med, Inc. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2025, and as of the date of this report, we assessed our financial condition and concluded that based on our current and projected cash resources and commitments, as well as other factors mentioned above, there is a substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2025
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| — | -$3000 | $20K | -$6000 | — | — | |
| $535K | $710K | $2.06M | $1.89M | $1.42M | $409K | |
| $902K | $1.01M | $2.03M | $2.12M | $1.37M | $321K | |
| -$1.46M | -$1.94M | -$4.91M | -$4.76M | -$3.68M | -$730K | |
| -$415K | -$6000 | $2000 | $28K | -$41K | -$22K | |
| — | $1.9M | $4.91M | $4.73M | $3.72M | -$752K | |
| -$2.35M | -$1.9M | -$4.91M | -$4.73M | -$3.72M | -$752K | |
| USD/shares | -$0.03 | -$0.03 | -$0.07 | -$0.07 | -$0.06 | — |
| USD/shares | -$0.03 | -$0.03 | -$0.07 | -$0.07 | — | — |
| shares | — | — | 69.4M | 67.58M | 63.11M | 30.03M |
| shares | — | 70.47M | 69.4M | 67.58M | — | — |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Convertible debt, including current maturities | 2025-06-30 | USD 32,000 | 10-Q filed 2025-08-14 |
| Current operating lease liabilities | 2025-06-30 | USD 16,000 | 10-Q filed 2025-08-14 |
| Current portion of loans payable | 2025-06-30 | USD 176,000 | 10-Q filed 2025-08-14 |
| Noncurrent operating lease liabilities | 2025-06-30 | USD 26,000 | 10-Q filed 2025-08-14 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.